Caplin, Lawrence – Trademark Portfolio
Entity Type: 01
Caplin, Lawrence holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include OHIP, DENTRUST DENTAL, JUST DO THE RIGHT THING, ORAL HEALTH IMPACT PROJECT, and GREAT SMILES ... GREAT FUTURES. The owner is based in Pipersville, PA.
256 Cafferty Rd
Pipersville, PA 18947
Showing of trademarks Trademarks
Trademark Classifications
Caplin, Lawrence's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Caplin, Lawrence have?
Caplin, Lawrence has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 1 cancelled.
What trademark classes does Caplin, Lawrence file in?
Caplin, Lawrence files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Caplin, Lawrence's most well-known trademarks?
Caplin, Lawrence's registered trademark portfolio includes well-known marks such as OHIP, DENTRUST DENTAL, JUST DO THE RIGHT THING, ORAL HEALTH IMPACT PROJECT, and GREAT SMILES ... GREAT FUTURES. These are among 5 currently registered trademarks in the portfolio.
What is Caplin, Lawrence's trademark registration success rate?
Caplin, Lawrence has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.